What does MERCK LIFE SCIENCE do?

MERCK LIFE SCIENCE is a wholesaler in Hoeilaart. Private Limited, started on 16 March 1984, 1 establishment.

What is the address of MERCK LIFE SCIENCE?

The registered office of MERCK LIFE SCIENCE is located at Ildefonse Vandammestraat 5/7B, 1560 Hoeilaart.

Is MERCK LIFE SCIENCE still active?

Yes. According to the CBE (30 October 2026) MERCK LIFE SCIENCE is active, legal situation “Normale toestand”, started on 16 March 1984.

Is MERCK LIFE SCIENCE registered on Peppol?

Yes, MERCK LIFE SCIENCE is registered on the Peppol network with ID 0208:0425578392.

What is the enterprise number of MERCK LIFE SCIENCE?

The enterprise number of MERCK LIFE SCIENCE is BE0425578392.

When was MERCK LIFE SCIENCE founded?

MERCK LIFE SCIENCE was founded on 16 March 1984.

Who are the directors of MERCK LIFE SCIENCE?

According to the 2025 annual accounts, the directors of MERCK LIFE SCIENCE are: Ann Van Gyseghem, Spasena Ivanova Yotova.

Is MERCK LIFE SCIENCE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 March 1984; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MERCK LIFE SCIENCE make in 2025?

MERCK LIFE SCIENCE posted a profit after taxes of € 4,852,056 in financial year 2025.

What is the revenue of MERCK LIFE SCIENCE?

In its most recent annual accounts (2025), MERCK LIFE SCIENCE reported revenue of € 158,479,314.

How much does an employee at MERCK LIFE SCIENCE earn?

The average wage cost per full-time employee at MERCK LIFE SCIENCE was € 180,000 in 2025: staff costs of € 8.3 million for 46.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does MERCK LIFE SCIENCE have?

According to the 2025 annual accounts, MERCK LIFE SCIENCE has 46.3 full-time equivalents (FTE).

MERCK LIFE SCIENCE (Private Limited) - Hoeilaart

Dossier MERCK LIFE SCIENCE, printed on 30 October 2026 from databakkes.be/en/0425578392/merck-life-science. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MERCK LIFE SCIENCE from Hoeilaart, company number BE0425578392, closed financial year 2025 with a result of € 4.9 million after tax. For that financial year MERCK LIFE SCIENCE recorded revenue of € 158.5 million and equity of € 21.9 million. Compared with financial year 2024, the result moved from € 8.6 million to € 4.9 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What it is worth Healthy

€ 21.9 million

▼ 36% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 4.9 million

▼ 43% vs 2024

Profit after tax over the fiscal year.

Where the profit goes Pays out

€ 17 million paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

46.3

▼ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 3.6 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 8.3 million

▲ 14% vs 2024

€ 180,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

€ 0

▼ 99% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 716,382

▲ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 2 days on average.

Taxes and wages

€ 4.3 million

▲ 10% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 172,718,355 Revenue 2022: € 172,718,355 First fiscal year in the series	€ 171,326,726 Revenue 2023: € 171,326,726 ▼ 1% vs 2022 (€ 172,718,355) Unfavourable step	€ 161,189,300 Revenue 2024: € 161,189,300 ▼ 6% vs 2023 (€ 171,326,726) Unfavourable step	€ 158,479,314 Revenue 2025: € 158,479,314 ▼ 2% vs 2024 (€ 161,189,300) Unfavourable step	▼ 2%
Profit after taxes	€ 7,903,672 Profit after taxes 2022: € 7,903,672 First fiscal year in the series	€ 10,074,167 Profit after taxes 2023: € 10,074,167 ▲ 27% vs 2022 (€ 7,903,672) Favourable step	€ 8,555,503 Profit after taxes 2024: € 8,555,503 ▼ 15% vs 2023 (€ 10,074,167) Unfavourable step	€ 4,852,056 Profit after taxes 2025: € 4,852,056 ▼ 43% vs 2024 (€ 8,555,503) Unfavourable step	▼ 43%
Equity	€ 30,412,200 Equity 2022: € 30,412,200 First fiscal year in the series	€ 25,486,368 Equity 2023: € 25,486,368 ▼ 16% vs 2022 (€ 30,412,200) Unfavourable step	€ 34,041,871 Equity 2024: € 34,041,871 ▲ 34% vs 2023 (€ 25,486,368) Favourable step	€ 21,893,926 Equity 2025: € 21,893,926 ▼ 36% vs 2024 (€ 34,041,871) Unfavourable step	▼ 36%
Total debts	€ 23,119,045 Total debts 2022: € 23,119,045 First fiscal year in the series	€ 23,489,841 Total debts 2023: € 23,489,841 ▲ 2% vs 2022 (€ 23,119,045) Unfavourable step	€ 5,409,277 Total debts 2024: € 5,409,277 ▼ 77% vs 2023 (€ 23,489,841) Favourable step	€ 22,689,561 Total debts 2025: € 22,689,561 ▲ € 17.3 million vs 2024 (€ 5,409,277) Unfavourable step	▲ € 17.3 million
Cash	€ 23,692,701 Cash 2022: € 23,692,701 First fiscal year in the series	€ 27,521,418 Cash 2023: € 27,521,418 ▲ 16% vs 2022 (€ 23,692,701) Favourable step	-	-
Retained profit	€ 11,200 Retained profit 2022: € 11,200 First fiscal year in the series	€ 11,200 Retained profit 2023: € 11,200 Unchanged (€ 11,200) Unchanged	€ 8,566,703 Retained profit 2024: € 8,566,703 ▲ € 8.6 million vs 2023 (€ 11,200) Favourable step	€ 11,200 Retained profit 2025: € 11,200 ▼ € 8.6 million vs 2024 (€ 8,566,703) Unfavourable step	▼ € 8.6 million
Dividend	€ 13,000,000 Dividend 2022: € 13,000,000 First fiscal year in the series	€ 15,000,000 Dividend 2023: € 15,000,000 ▲ 15% vs 2022 (€ 13,000,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 15,000,000) Unchanged	€ 17,000,000 Dividend 2025: € 17,000,000 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 59 Bank debt 2024: € 59 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 99% vs 2024 (€ 59) Favourable step	▼ 99%
Balance sheet total	€ 53,623,435 Balance sheet total 2022: € 53,623,435 First fiscal year in the series	€ 53,692,140 Balance sheet total 2023: € 53,692,140 Unchanged (€ 53,623,435) Unchanged	€ 39,452,811 Balance sheet total 2024: € 39,452,811 ▼ 27% vs 2023 (€ 53,692,140) Unchanged	€ 46,122,833 Balance sheet total 2025: € 46,122,833 ▲ 17% vs 2024 (€ 39,452,811) Unchanged	▲ 17%
Employees (FTE)	43.4 Employees (FTE) 2022: 43.4 First fiscal year in the series	45.6 Employees (FTE) 2023: 45.6 ▲ 2.2 vs 2022 (43.4) Unchanged	47.1 Employees (FTE) 2024: 47.1 ▲ 1.5 vs 2023 (45.6) Unchanged	46.3 Employees (FTE) 2025: 46.3 ▼ 0.8 vs 2024 (47.1) Unchanged	▼ 0.8

Key figures of MERCK LIFE SCIENCE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MERCK LIFE SCIENCE?

What happened at MERCK LIFE SCIENCE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 19, 2026 New annual accounts for financial year 2025: profit of € 4.9 million (▼ 43% vs 2024). Source: NBB ↗
2025 Spasena Ivanova Yotova became a director. NBB
2021 Ann Van Gyseghem became a director. NBB
Jun 22, 1992 New establishment in Hoeilaart. KBO
Mar 16, 1984 Start of the company according to the CBE. KBO

In short

From € 7.9 million profit in 2022 to € 4.9 million profit in 2025.

Paid € 10.9 million in corporate taxes since 2022.

Best year ever: 2023, with € 10.1 million profit.

Paid out € 45 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

MERCK CHEMICALS NV 100%

Millipore International Holdings S.à r.l. 0%

MERCK LIFE SCIENCE

Behind MERCK LIFE SCIENCE are Ann Van Gyseghem and Spasena Ivanova Yotova. The shares are held by MERCK CHEMICALS NV (100%) and Millipore International Holdings S.à r.l. (0%).

Directors

According to the 2025 annual accounts

Ann Van Gyseghem

Manager

since 2021

Spasena Ivanova Yotova

Manager

Also active at: MERCK, Merck Chemicals NV/SA

since 2025

Shareholders

MERCK CHEMICALS NV

100%

Millipore International Holdings S.à r.l.

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Ildefonse Vandammestraat 5/7B

1560 Hoeilaart

2.024.525.305

Ildefonse Vandammestraat 5/7 box B

1560 Hoeilaart

Active since 22 June 1992

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

MERCK same network

€ 42.6 million revenue · 2025

Merck Chemicals NV/SA same network

€ 2.2 million revenue · 2025

Merck Life Science MPS

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0425.578.392

VAT number

BE 0425.578.392

Registered office

Ildefonse Vandammestraat 5/7B, 1560 Hoeilaart

Names & denominations

MERCK LIFE SCIENCE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 March 1984

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Groothandel in chemische producten voor industrieel gebruik

Groothandel in chemische producten

Groothandel in farmaceutische en medische artikelen

Groothandel in andere intermediaire producten, neg

Groothandel in andere intermediaire producten, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

MERCK LIFE SCIENCE

Financials

What happened to MERCK LIFE SCIENCE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions